Navinta LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1499 Lower Ferry Road, Ewing, New Jersey (NJ) 08618, United States (USA)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3004375014 · DUNS 130443810
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2024-09-30
- NAIBioresearch Monitoring2023-05-04
- VAIBioresearch Monitoring2019-03-28
- VAIPostmarket Surv. and Epidemiology2017-08-18
- OAIBioresearch Monitoring2016-05-16
- NAIDrug Quality Assurance2015-08-10
Drugs this plant is listed as making
2 distinct drugs across 4 products name this site in their FDA label.
- carmustineNavinta LLC
- Remifentanil Hydrochloridein shortageHikma Pharmaceuticals USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.